<VariationArchive VariationID="483563" VariationName="NM_000249.4(MLH1):c.1923del (p.Leu641_Leu642insTer)" VariationType="Deletion" Accession="VCV000483563" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2018-01-01" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="473471" VariationID="483563">
      <GeneList>
        <Gene Symbol="MLH1" FullName="mutL homolog 1" GeneID="4292" HGNC_ID="HGNC:7127" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="36993466" stop="37050846" display_start="36993466" display_stop="37050846" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="37034840" stop="37092336" display_start="37034840" display_stop="37092336" Strand="+" />
          </Location>
          <OMIM>120436</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000249.4(MLH1):c.1923del (p.Leu641_Leu642insTer)</Name>
      <CanonicalSPDI>NC_000003.12:37048541:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="37048542" stop="37048542" display_start="37048542" display_stop="37048542" variantLength="1" positionVCF="37048541" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="37090033" stop="37090033" display_start="37090033" display_stop="37090033" variantLength="1" positionVCF="37090032" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.37090034del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.37090034del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.37048543del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.37048543del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007109.2" sequenceAccession="NG_007109" sequenceVersion="2" change="g.60194del">
            <Expression>NG_007109.2:g.60194del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000249.4" sequenceAccession="NM_000249" sequenceVersion="4" change="c.1923del" MANESelect="true">
            <Expression>NM_000249.4:c.1923del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000240.1" sequenceAccession="NP_000240" sequenceVersion="1" change="p.Leu641_Leu642insTer">
            <Expression>NP_000240.1:p.Leu641_Leu642insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167617.3" sequenceAccession="NM_001167617" sequenceVersion="3" change="c.1629del">
            <Expression>NM_001167617.3:c.1629del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161089.1" sequenceAccession="NP_001161089" sequenceVersion="1" change="p.Leu543_Leu544insTer">
            <Expression>NP_001161089.1:p.Leu543_Leu544insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167618.3" sequenceAccession="NM_001167618" sequenceVersion="3" change="c.1200del">
            <Expression>NM_001167618.3:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161090.1" sequenceAccession="NP_001161090" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001161090.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167619.3" sequenceAccession="NM_001167619" sequenceVersion="3" change="c.1200del">
            <Expression>NM_001167619.3:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161091.1" sequenceAccession="NP_001161091" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001161091.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258273.2" sequenceAccession="NM_001258273" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001258273.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245202.1" sequenceAccession="NP_001245202" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001245202.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258274.3" sequenceAccession="NM_001258274" sequenceVersion="3" change="c.1200del">
            <Expression>NM_001258274.3:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001245203.1" sequenceAccession="NP_001245203" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001245203.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354615.2" sequenceAccession="NM_001354615" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001354615.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341544.1" sequenceAccession="NP_001341544" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001341544.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354616.2" sequenceAccession="NM_001354616" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001354616.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341545.1" sequenceAccession="NP_001341545" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001341545.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354617.2" sequenceAccession="NM_001354617" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001354617.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341546.1" sequenceAccession="NP_001341546" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001341546.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354618.2" sequenceAccession="NM_001354618" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001354618.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341547.1" sequenceAccession="NP_001341547" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001341547.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354619.2" sequenceAccession="NM_001354619" sequenceVersion="2" change="c.1200del">
            <Expression>NM_001354619.2:c.1200del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341548.1" sequenceAccession="NP_001341548" sequenceVersion="1" change="p.Leu400_Leu401insTer">
            <Expression>NP_001341548.1:p.Leu400_Leu401insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354620.2" sequenceAccession="NM_001354620" sequenceVersion="2" change="c.1629del">
            <Expression>NM_001354620.2:c.1629del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341549.1" sequenceAccession="NP_001341549" sequenceVersion="1" change="p.Leu543_Leu544insTer">
            <Expression>NP_001341549.1:p.Leu543_Leu544insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354621.2" sequenceAccession="NM_001354621" sequenceVersion="2" change="c.900del">
            <Expression>NM_001354621.2:c.900del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341550.1" sequenceAccession="NP_001341550" sequenceVersion="1" change="p.Leu300_Leu301insTer">
            <Expression>NP_001341550.1:p.Leu300_Leu301insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354622.2" sequenceAccession="NM_001354622" sequenceVersion="2" change="c.900del">
            <Expression>NM_001354622.2:c.900del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341551.1" sequenceAccession="NP_001341551" sequenceVersion="1" change="p.Leu300_Leu301insTer">
            <Expression>NP_001341551.1:p.Leu300_Leu301insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354623.2" sequenceAccession="NM_001354623" sequenceVersion="2" change="c.900del">
            <Expression>NM_001354623.2:c.900del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341552.1" sequenceAccession="NP_001341552" sequenceVersion="1" change="p.Leu300_Leu301insTer">
            <Expression>NP_001341552.1:p.Leu300_Leu301insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354624.2" sequenceAccession="NM_001354624" sequenceVersion="2" change="c.849del">
            <Expression>NM_001354624.2:c.849del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341553.1" sequenceAccession="NP_001341553" sequenceVersion="1" change="p.Leu283_Leu284insTer">
            <Expression>NP_001341553.1:p.Leu283_Leu284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354625.2" sequenceAccession="NM_001354625" sequenceVersion="2" change="c.849del">
            <Expression>NM_001354625.2:c.849del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341554.1" sequenceAccession="NP_001341554" sequenceVersion="1" change="p.Leu283_Leu284insTer">
            <Expression>NP_001341554.1:p.Leu283_Leu284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354626.2" sequenceAccession="NM_001354626" sequenceVersion="2" change="c.849del">
            <Expression>NM_001354626.2:c.849del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341555.1" sequenceAccession="NP_001341555" sequenceVersion="1" change="p.Leu283_Leu284insTer">
            <Expression>NP_001341555.1:p.Leu283_Leu284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354627.2" sequenceAccession="NM_001354627" sequenceVersion="2" change="c.849del">
            <Expression>NM_001354627.2:c.849del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341556.1" sequenceAccession="NP_001341556" sequenceVersion="1" change="p.Leu283_Leu284insTer">
            <Expression>NP_001341556.1:p.Leu283_Leu284insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354629.2" sequenceAccession="NM_001354629" sequenceVersion="2" change="c.1824del">
            <Expression>NM_001354629.2:c.1824del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341558.1" sequenceAccession="NP_001341558" sequenceVersion="1" change="p.Leu608_Leu609insTer">
            <Expression>NP_001341558.1:p.Leu608_Leu609insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354630.2" sequenceAccession="NM_001354630" sequenceVersion="2" change="c.1758del">
            <Expression>NM_001354630.2:c.1758del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341559.1" sequenceAccession="NP_001341559" sequenceVersion="1" change="p.Leu586_Leu587insTer">
            <Expression>NP_001341559.1:p.Leu586_Leu587insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354628.2" sequenceAccession="NM_001354628" sequenceVersion="2" change="c.1897-361del">
            <Expression>NM_001354628.2:c.1897-361del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258271.2" sequenceAccession="NM_001258271" sequenceVersion="2" change="c.1896+860del">
            <Expression>NM_001258271.2:c.1896+860del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_216" sequenceAccession="LRG_216">
            <Expression>LRG_216:g.60194del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000249.3" sequenceAccession="NM_000249" sequenceVersion="3" change="c.1923delT">
            <Expression>NM_000249.3:c.1923delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658655796" DB="ClinGen" />
        <XRef Type="rs" ID="1553663834" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000249.4(MLH1):c.1923del (p.Leu641_Leu642insTer) AND Hereditary cancer-predisposing syndrome" Accession="RCV000562631" Version="3">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.1923del (p.Leu641_Leu642insTer) AND Carcinoma of colon" Accession="RCV001355485" Version="2">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000249.4(MLH1):c.1923del (p.Leu641_Leu642insTer) AND Colorectal cancer, hereditary nonpolyposis, type 2" Accession="RCV003451245" Version="1">
        <ClassifiedConditionList TraitSetID="5637">
          <ClassifiedCondition DB="MedGen" ID="C1333991">Colorectal cancer, hereditary nonpolyposis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-24" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-01-01" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22854115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26248088</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4825" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Colorectal cancer, hereditary nonpolyposis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MLH1-Related Lynch Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lynch syndrome II</ElementValue>
                <Citation Type="general" Abbrev="Vasen et al., 2007">
                  <ID Source="pmc">2740877</ID>
                </Citation>
                <XRef ID="Colorectal+Cancer%2C+Hereditary+Nonpolyposis%2C+Type+2/1749" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HNPCC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COCA2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FCC2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000508789" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508803" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000317453" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520048" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505560" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501396" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508795" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332358" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000326160" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260599" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15457" />
                <XRef ID="15457" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MLH1-Related Hereditary Non-Polyposis Colon Cancer</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="practice guideline" Abbrev="SGO, 2014">
                <URL>https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer</URL>
                <CitationText>Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="MSTF, 2014">
                <ID Source="PubMed">25070057</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mork et al., 2015">
                <ID Source="PubMed">25711197</ID>
              </Citation>
              <Citation Type="general" Abbrev="Dutch SCG, 2013">
                <ID Source="PubMed">23535968</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2013">
                <ID Source="PubMed">23408351</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC/CCA-ICC, 2012">
                <ID Source="PubMed">22167527</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1333991" DB="MedGen" />
              <XRef ID="MONDO:0012249" DB="MONDO" />
              <XRef Type="MIM" ID="609310" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1304995" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-01-01">
        <ClinVarSubmissionID localKey="a683283|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000669577" DateUpdated="2024-05-01" DateCreated="2018-01-01" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22854115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26248088</ID>
          </Citation>
          <Comment>The c.1923delT pathogenic mutation, located in coding exon 17 of the MLH1 gene, results from a deletion of one nucleotide at nucleotide position 1923, causing a translational frameshift with a predicted alternate stop codon. A study of 25 Jamaican early-onset (&lt;40 years old) colorectal cancer patients identified this mutation in one patient with a MSI-H tumor (Plummer JM et al. Can J Surg, 2012 Oct;55:294-300). This mutation was also found in 1/57 African American probands with colorectal cancer in a retrospective study assessing the colorectal cancer risk and mutation spectrum in African American families with Lynch syndrome (Guindalini RS et al. Gastroenterology, 2015 Nov;149:1446-53). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000249.3:c.1923delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3051208" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr3:37090031-37090033:e6d20c0851492a806943d1f99dbdd921-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001550387" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MLH1 p.Leu642* variant was identified in 2 of 164 proband chromosomes (frequency: 0.01) from individuals or families with colorectal cancer (Guindalini 2015, Plimmer 2012). The variant was also identified in ClinVar (classified as pathogenic by Ambry Genetics). The variant was not identified in dbSNP, COGR, Cosmic, UMD-LSDB, Zhejiang University Database, Mismatch Repair Genes Variant Database, the Insight Hereditary Tumors database, the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.1923delT variant leads to a premature stop codon at position 642, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the MLH1 gene are an established mechanism of disease in Lynch syndrome and this is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CT" start="37090032" stop="37090033" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7829253" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="100710974|OMIM:609310" />
        <ClinVarAccession Accession="SCV004189933" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="3" alternateAllele="T" referenceAllele="TT" start="37090033" stop="37090034" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">100710974</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609310" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1304995" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829253" TraitType="Disease" MappingType="XRef" MappingValue="609310" MappingRef="OMIM">
        <MedGen CUI="C1333991" Name="Colorectal cancer, hereditary nonpolyposis, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3051208" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

